Between The Lines
A journal club review of “Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in phase 3 randomized clinical trial in patients with narcolepsy,” by Kushida CA, et al.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Podcast: Practical Insights Into the Evolving Treatment of Bipolar Disorder With David Dunner, MD, FACPsych
2
New Phase 3 Post Hoc Analyses of Centanafadine for the Treatment of Adults With ADHD
3
Preventing Relapse in Schizophrenia: Focus on Women’s Mental Health
4
Seltorexant as Adjunctive Therapy for MDD With Insomnia
5